ICYMI: Last week we posted our January dashboard, which tracks our progress towards creating the MOHCCN Gold Cohort.

This dashboard gets published every month on the home page of the MOHCCN website ▶ lnkd.in/d5ePe7DE

Honoring Dr. Katy Rezvani, a true (cord blood) hero! Thank you for this piece Samer Al Hadidi, MD,MS,FACP Abdul Rafae
#ASH23

Hope for the future of sickle cell disease. Hilary Whitworth getting us all the details on new therapeutics and what they mean. Excellent read!
#ASH23

These two! Beautiful coverage of the Ernest Beutler Prize awardees.

Your round-up on what’s new in the AML therapeutic landscape!
Diego Adrianzen-Herrera, MD
#ASH23

We are the lucky ones!!! Was it ever a wild ride. All about the science… but really about the people. An honor and privilege to be just a small part of it. The entire team worked magic and we’re so grateful to them!
#ASH2023 #ASHNewsDailyLove

#ASH23 News Daily Monday AM edition is out. Our piece ‘It’s time to sp(l)ice things up’ covers fantastic work by Salima Benbarche Abdel-Wahab Lab, which was presented at #ASH23 Plenary Session. ASH. Read it here: ashpublications.org/ashnewsdaily/n…

Natasha Szuber Juliana Perez Botero MD (she/her) 🌈

Rare MPN get their time in the spotlight! Fascinating session, outstanding work and passionate presenters!

An amazing rare MPN/ mast cell focused session kicking off with the fascinating concept of fedratinib for CNL aCML from Andrew Kuykendall MD @mpnsm

Our own #MeganSearsSmith & ⁦Brittany Knick Ragon, MD⁩ discuss impactful session on #Quality at #ASH23 in todays #ASHDailyNews #IntegratedCancerCenter ⁦Levine Cancer⁩ ⁦Wake Forest Baptist - Comprehensive Cancer Center⁩ ⁦Wake Forest University School of Medicine⁩ ⁦Atrium Health⁩ ⁦Sarada Krishnamurthy, MD, FACP (she/her/hers)⁩ ⁦Dianna S Howard⁩

You’re living my DREAM!!!😝

Meg, Leuk, and Red!! Thanks to Robert Brodsky for a lovely ASH President’s Reception. #ASH23 ASH

Juliana Perez Botero MD (she/her) 🌈 I know this was a labor of love!! Now if you could make me some abstract stickers (especially the little guy in the baseball cap), my life would be fully made. #ASH23 #ASHNewsDaily #ASHKudos ASH BioRender Natasha Szuber

Our poster (3192) on allo-HCT in MPN-AP/BP in the current era of myeloid therapies #ASH23
-65 of 202 pt received allo-HCT
-median OS 2.3 years from time of allo-HCT
-no diff in OS based on first-line tx for MPN-AP/BP or response prior to allo

#ASH23 News Daily Saturday Edition is out. Our piece ‘Leave no patient behind’ highlights ASH’s educational sessions on rare conditions and special populations, chaired by Anita D'Souza, Tamara P. Miller, and Emma M. Groarke. Read it here: ashpublications.org/ashnewsdaily/n…

Make sure the ASH Choosing Wisely Champions Special-Interest Session ➡️Monday, 12:15 p.m. to 1:15 p.m, is on your #ASH23 schedule.

ASH Nadine Abdallah Naseema Gangat Samer Al Hadidi, MD,MS,FACP

#ASHKudos back to an all time great. If you are searching for a mentor, be sure to find one who brings light to those around them. The really good mentors will pass that light on and on and on, and then the world becomes a very bright place. Naveen Pemmaraju, MD Levine Cancer #TeamPemm

🚨🔔MUST ATTEND! 430pm today Room 6B. Tackling the Greater Burden of #MultipleMyeloma in #AfricanAmerican Patients! Will be an informative session with experts Yvonne Efebera and Srinivas Devarakonda! ASH Yelak Biru Samer Al Hadidi, MD,MS,FACP Rayne Rouse

I’ll be moderating #ASH23 Session 906: Outcomes Research - Myeloid Malignancy, with focus on risk factors and health disparities. Join Wellington Fernandes and myself at 4pm - Marriott Ballroom 11-13. ASH #OutcomesResearch

Grab a coffee at #ASH23 (mine a “quad” flat white) remove the Reblozyl add from the cover of your #ASHDailyNews and read our own ⁦Brittany Knick Ragon, MD⁩ wonderful piece previewing today’s Laboratory Correlates in Clinical Trials session! ⁦Levine Cancer⁩ ⁦Wake Forest University School of Medicine⁩